ライフサイエンスコーパス: drug absorption

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 e of IUDs, have extremely low or no systemic drug absorption.

2 formulation in vivo and consequently affect drug absorption.

3 ASBT) may serve as a prodrug target for oral drug absorption.

4 e of 100 to 1,600 mg/d, suggesting saturable drug absorption.

5 hich simultaneously improve both potency and drug absorption.

6 Given its role in intestinal drug absorption, a detailed analysis of the mechanisms t

7 Amino acid (and related drug) absorption across the human small intestinal wall

8 lidation and determining the role of P-gp in drug absorption and disposition.

9 shown to play an important role in limiting drug absorption and distribution and in enhancing drug c

10 ycoprotein may play an important role in net drug absorption and drug/drug interactions of shared CYP

11 and drugs to predict the impact of lipids on drug absorption and enable rational design of lipid-base

12 of these agents may be to enhance intestinal drug absorption and increase drug penetration to biologi

13 epithelial damage caused increased systemic drug absorption and penetration of MPP into colorectal t

14 thylbenz[a]anthracene in vivo, demonstrating drug absorption and tissue distribution leading to pharm

15 is apparently nearly entirely accessible to drug absorption, and (iv) the relative "leakiness" of th

16 oing PPCI, crushed prasugrel leads to faster drug absorption, and consequently, more prompt and poten

17 ples can be used to directly measure topical drug absorption, biopsies are invasive and not practical

18 lipid system function and overall impact on drug absorption can aid in the understanding of drug-lip

19 doresistance, reflecting delayed and reduced drug absorption, complicates enteric coated but not imme

20 ics in vivo and the consequential effects on drug absorption distribution, metabolism, excretion, and

21 s associated with critical illness may alter drug absorption, distribution, and clearance, and concom

22 unt of important environmental influences on drug absorption, distribution, metabolism and excretion.

23 These properties, which include drug absorption, distribution, metabolism, and excretion

24 currently under investigation as a potential drug absorption enhancer.

25 ux are two important biochemical barriers to drug absorption from the intestine.

26 r-Nelson method to obtain percent of in vivo drug absorption in postmenopausal women.

27 ontributing factor to poor immunosuppressive drug absorption in this patient and others.

28 dhesion to intestinal mucosa, enhancement of drug absorption in vitro (Caco-2 monolayer transport) an

29 It is thus important to address the issue of drug absorption into device material.

30 We investigated drug absorption into microfluidic devices by treating mu

31 his interplay and its potential relevance to drug absorption is an important goal, as a large proport

32 The effect of lipids on drug absorption is currently not quantitatively predicta

33 n (CPR) is <20% of normal, and transalveolar drug absorption is likely to be minimal.

34 Ensuring reliable gastrointestinal drug absorption of orally administered immunosuppressive

35 means to increase the low and variable oral drug absorption of transporter substrates while decreasi

36 me, no patients had a history of liver toxic drug absorption, patent viral infection, or any histopat

37 The site of drug absorption was revealed by high spatial resolution

38 hanges in the lung can also result in slower drug absorption, which is further compounded by disease

39 f drug permeation (X) and in vivo percent of drug absorption (Y) for these three estradiol TDDS was c

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。